Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
HBB and thalassemia are reported together in 6 articles.
Gene
HBB
- HGNC
- HGNC:4827
38articles
38mentions
2variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
Phenotype
Thalassemia
- HPO
- HP:0001878
409articles
409mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
6 records shown · first 60Systematic Review of Non-Coding Genomic Variants in Globin and Non-Globin Clusters and Their Impact on Phenotypic Severity in Thalassemia and Sickle Cell Disease.
PMID 41753033 | PMCID PMC12941110 | DOI 10.3390/jcm15041345 · Journal of clinical medicine · 2026 · 7 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | HBB | “The first major group comprises cis-acting variants within globin gene clusters (HBG2 promoter XmnI polymorphism, HBB promoter mutations and α-globin enhancer variants), while the second major group comprises trans-acting quantitative trait loci (QTLs) (BCL11A and HBS1L-MYB loci).” | 0.98 | hgnc_dict_v1 |
| phenotype | thalassemia | “Systematic Review of Non-Coding Genomic Variants in Globin and Non-Globin Clusters and Their Impact on Phenotypic Severity in Thalassemia and Sickle Cell Disease.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | HBG2 | “The first major group comprises cis-acting variants within globin gene clusters (HBG2 promoter XmnI polymorphism, HBB promoter mutations and α-globin enhancer variants), while the second major group comprises trans-acting quantitative trait loci (QTLs) (BCL11A and HBS1L-MYB loci).” | 0.98 | hgnc_dict_v1 |
| gene | BCL11A | “The first major group comprises cis-acting variants within globin gene clusters (HBG2 promoter XmnI polymorphism, HBB promoter mutations and α-globin enhancer variants), while the second major group comprises trans-acting quantitative trait loci (QTLs) (BCL11A and HBS1L-MYB loci).” | 0.98 | hgnc_dict_v1 |
Identification of seven novel variants in the β-globin gene in transfusion-dependent and normal patients.
PMID 32190157 | PMCID PMC7069418 | DOI 10.5114/aoms.2019.84825 · Archives of medical science : AMS · 2020 · 12 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | HBB | “INTRODUCTION: Abnormality in HBB results in an inherited recessive blood disorder, which can be caused by variants at the transcriptional or translational level affecting the stability and the production of the HBB chain.” | 0.98 | hgnc_dict_v1 |
| phenotype | thalassemia | “The identified β-globin mutations will strengthen the genetic reference that could aid in characterizing mutations that are associated with phenotype of thalassemia in a specific region.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | HBA1 | “MATERIAL AND METHODS: Direct sequence of β-globin HBB gene, and alpha-globin HBA1 and HBA2 genes was performed on a total of 545 blood samples (transfusion-dependent: 215, 106 men and 109 women; normal healthy subjects: 330, 197 men and 133 women) collected from Saudi Arabian participants in the Eastern region.” | 0.98 | hgnc_dict_v1 |
| gene | HBA2 | “MATERIAL AND METHODS: Direct sequence of β-globin HBB gene, and alpha-globin HBA1 and HBA2 genes was performed on a total of 545 blood samples (transfusion-dependent: 215, 106 men and 109 women; normal healthy subjects: 330, 197 men and 133 women) collected from Saudi Arabian participants in the Eastern region.” | 0.98 | hgnc_dict_v1 |
CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.
PMID 32912325 | PMCID PMC7488347 | DOI 10.1186/s13287-020-01876-4 · Stem cell research & therapy · 2020 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | HBB | “BACKGROUND: β-Thalassemias represent a group of genetic disorders caused by human hemoglobin beta (HBB) gene mutations.” | 0.98 | hgnc_dict_v1 |
| phenotype | thalassemia | “CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | CD34 | “METHODS AND RESULTS: We successfully isolated CD34+ cells from peripheral blood of β-thalassemia patients with IVS-1-110 mutation.” | 0.98 | hgnc_dict_v1 |
| variant | IVS-1-110 | “CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.” | 0.82 | literature_variant_regex_v2 |
Computational Analysis of Protein Structure Changes as a Result of Nondeletion Insertion Mutations in Human β-Globin Gene Suggests Possible Cause of β-Thalassemia.
PMID 31275994 | PMCID PMC6582885 | DOI 10.1155/2019/9210841 · BioMed research international · 2019 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | HBB | “Most of the defects in hemoglobin arise directly from the mutations in the structural β-globin gene (HBB).” | 0.98 | hgnc_dict_v1 |
| phenotype | thalassemia | “Beta-thalassemia is described as a group of hereditary blood disorders characterized by abnormalities in the synthesis of beta chains of hemoglobin.” | 0.93 | phenotype_alias_lexicon_v2 |
A comprehensive review of the prevalence of beta globin gene variations and the co-inheritance of related gene variants in Saudi Arabians with beta-thalassemia.
PMID 29619482 | PMCID PMC5938644 | DOI 10.15537/smj.2018.4.21360 · Saudi medical journal · 2018 · 8 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | HBB | “Beta-thalassemia is a genetic disorder that is caused by variations in the beta-hemoglobin (HBB) gene.” | 0.98 | hgnc_dict_v1 |
| phenotype | thalassemia | “A comprehensive review of the prevalence of beta globin gene variations and the co-inheritance of related gene variants in Saudi Arabians with beta-thalassemia.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | ATRX | “The coinheritance of HBB gene variations with ATRX, HBA1, HBA2, HBA12, AHSP, and KLF1 gene variations were observed to be common in the Saudi population.” | 0.98 | hgnc_dict_v1 |
| gene | HBA1 | “The coinheritance of HBB gene variations with ATRX, HBA1, HBA2, HBA12, AHSP, and KLF1 gene variations were observed to be common in the Saudi population.” | 0.98 | hgnc_dict_v1 |
Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
PMID 26076396 | DOI 10.3109/03630269.2015.1053489 · Hemoglobin · 2015 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | HBB | “There were 41 patients, made up of 20 with β-thalassemia intermedia (β-TI), 18 with Hb H (β4) disease and three with Hb E (HBB: c.79G > A)-β-thalassemia (Hb E-β-thal); their ages ranged from 3 to 36 years (mean 12.5 ± 7.7).” | 0.98 | hgnc_dict_v1 |
| phenotype | thalassemia | “Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.” | 0.98 | phenotype_alias_lexicon_v2 |
| population | Saudi Arabia | “There were 41 patients, made up of 20 with β-thalassemia intermedia (β-TI), 18 with Hb H (β4) disease and three with Hb E (HBB: c.79G > A)-β-thalassemia (Hb E-β-thal); their ages ranged from 3 to 36 years (mean 12.5 ± 7.7). The most common mutations among the β-TI patients were IVS-II-1 (G > A) and IVS-I-6 (T > C), while among the Hb H patients, the Saudi α2-globin gene polyadenylation (polyA) (AATAAA > AATAAG) mutation was responsible for all cases either as homozygotes (61.1%) or compound heterozygotes with the α-thal-2 (-α(3.7)) allele (33.3%).” | 0.95 | saudi_context_rules_v1 |